- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01422174
Clinical Registry on Sudden Death Primary Prevention at Latin America (ESCAPE-ICD)
Clinical Registry on Sudden Death Primary Prevention at Latin America (rEgiStro Clinico en America Latina de Prevencion Primaria en muErte Subita)
INTRODUCTION: Sudden cardiac death is one of the most important reasons of death at industrialized countries. Despite its importance, nowadays Clinical Guidelines are not as extended as expected, with respect to indications for primary prevention defibrillator implantation, following MADIT II and MUSTT criteria, especially at Latin American countries.
OBJECTIVES: This Project is designed with the purpose of providing tools to help spreading primary prevention by the means of clinical evidence on real risk of death in this group of patients.
REGISTRY DESIGN:
- retrospective (at stage 1); prospective (at stage 2)
- multi-center (minimum 25-30 centres)
- international (Argentina, Brazil, Colombia, Chile, Mexico and Venezuela)
- non randomized.
- Sample size: at screening about 12.500 patients and 962 patients at treatment stage
REGISTRY DEVICES: CE marked (Conformité Européenne) single-chamber, dual-chamber or CRT (Cardiac Resynchronization Therapy) implantable cardiac defibrillator (ICD).
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
REGISTRY STAGES 2 stages will be performed:
- Stage 1 (Screening): 12500 patients with MI and LVEF<40% will be evaluated, to know ICD implantation prevalence in such patients at Latin American countries
- Stage 2 (Treatment): after patient screening and as per clinical decision, 962 patients will be entered in group 1 and 2 (481 each, 1:1)
STEERING COMMITTEE
- Dr. Sergio Dubner. Clinica y Maternidad Suizo Argentina and De Los Arcos Sanatorio. Buenos Aires - Argentina
- Dr. William Uribe. CES CARDIOLOGIA. Medellin - Colombia
CLINICAL ASSESSMENT
• Dr Francisco Javier Alzueta Rodriguez. Hospital Clinico Universitario Virgen de la Victoria. Malaga - Spain
REGISTRY DURATION
- Patient enrollment period initiation: September 2011
- End of patient enrollment: September 2013
- End of FUs: September 2018
- Registry closure and data analyses: 4Q 2018.
REGULATORY CONSIDERATIONS As this is an observational registry, no submission to National Authorities is required.
Undersøgelsestype
Kontakter og lokationer
Studiesteder
-
-
-
Tucuman, Argentina
- Centro Privado de Cardiología
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Patients that had Acute Myocardial Infarction (>40 days post-AMI) documented with the presence of Q-wave or cardiac-specific enzymatic markers of myocardial necrosis (CK-MB/troponin), occurred within 3 years previous to enrollment / after June 2008.
- Left Ventricular Ejection Fraction (LVEF) ≤40% post-revascularization (if no revascularization, measurement performed <3 months previous to patient enrollment, >40 days post-AMI and >3 months post-revascularization -if applicable-).
Exclusion Criteria:
- Patient with an implanted ICD
- <18 years old
- Pregnant or breast feeding women
- Patients that are already participating in other Investigational Study or Registry
- Non signed patient informed consent or refusal from patient's reference physician to patient participation
- Patient inability to comply with protocol (assist to scheduled follow-ups), due to: residence displacement out of center's activity area; unstable geographical situation or at very long distance from the center; unstable medical and/or psychological condition
- Cardiac transplanted (or in transplant waiting list)
- Severe Heart Failure (or other co-morbidity: cancer, renal failure, etc.)
- Life expectancy lower than 1 year
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
ICD implantation
Patients that receive an ICD implantation (non randomized, by clinical decision) will enter this group
|
Standard ICD implantation (as per clinical decision)
Andre navne:
|
Non ICD implantation
Patients that do not receive ICD implantation (non randomized, by clinical decision); they can receive any other treatment (e.g.
antiarrhythmic drugs)
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Prevalence of patients with MADIT, MADIT II and MUST at Latin American countries
Tidsramme: Patients that suffered from MI in the last 3 years and during the enrollment period
|
Primary Outcome at Stage 1: Determine prevalence of patients with myocardial infarction and high risk of sudden death at Latin America, that fulfill inclusion criteria Primary Outcome at Stage 2: Compare MACE development in patients that receive ICD implantation vs patients that receive other type of treatment (non ICD) |
Patients that suffered from MI in the last 3 years and during the enrollment period
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Study incidence of Arrhythmic mortality and serious arrhythmic events, evaluated through remote monitoring
Tidsramme: 5 years (until end 2018)
|
5 years (until end 2018)
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Sergio J Dubner, MD, FACC, Clínica y Maternidad Suizo Argentina and De Los Arcos Sanatorio. Buenos Aires, Argentina
- Ledende efterforsker: William Uribe, MD, CES Cardiología. Medellin, Colombia
- Studiestol: Francisco J Alzueta Rodriguez (Study Clinical Advisor), Dr, Hospital Clínico Universitario Virgen de la Victoria. Málaga, Spain
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- TA098
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Myokardieinfarkt
-
Sichuan Provincial People's HospitalTilmelding efter invitationRest Gated Myocardial Perfusion Imaging ved hjertesvigtKina
-
Azienda Ospedaliero Universitaria Maggiore della...Università degli Studi del Piemonte Orientale "Amedeo Avogadro"Rekruttering
-
Peking University Third HospitalAfsluttet
-
Stanford UniversitySuspenderetMyocardial brodannelseForenede Stater
-
Izmir Bakircay UniversityAfsluttetMyokardiebro af kranspulsårenKalkun
-
Fondazione Policlinico Universitario Agostino Gemelli...Afsluttet
-
ITAB - Institute for Advanced Biomedical TechnologiesAzienda Ospedaliero, Universitaria Ospedali RiunitiAfsluttetMyokardiebro af kranspulsårenItalien
-
Centre Hospitalier Sud FrancilienAfsluttetAkut anterior koroidal infarkt (ACI) | Paramedian Pontine Infarction (IPP)Frankrig
-
RenJi HospitalAfsluttetSomatisk symptomlidelse | MyokardiebroKina
-
Imperial College LondonGuy's and St Thomas' NHS Foundation Trust; University Hospital Southampton... og andre samarbejdspartnereRekrutteringSlag | Neurokognitiv dysfunktion | Silent Cerebral Infarction | Vaskulær hjerneskadeDet Forenede Kongerige
Kliniske forsøg med Implantable Cardio Defibrillator (ICD),
-
Abbott Medical DevicesUniversity of WashingtonAfsluttetVentrikulær fibrillation | Ventrikulær takykardi | Kongestiv hjertesvigt | Pludselig hjertedød
-
Guidant CorporationAfsluttetVentrikulær fibrillationTyskland
-
Boston Scientific CorporationAfsluttetVentrikulær fibrillation | Ventrikulær takykardiDet Forenede Kongerige
-
Rigshospitalet, DenmarkRekrutteringKoronararteriesygdom | Ventrikulær fibrillation | Akut myokardieinfarkt | Hjertestop uden for hospitalet | Ventrikulær takykardi, vedvarendeDanmark
-
OhioHealthAbbott Medical DevicesTrukket tilbageVentrikulær fibrillation | Ventrikulær takykardiForenede Stater
-
Rhode Island HospitalUkendtDød, pludselig, hjertesygdomForenede Stater
-
University Hospital, SaarlandFriede Springer Herz StiftungAfsluttetHjertesvigtpatienter før og efter ICD-implantationTyskland
-
Gulf Heart AssociationBoston Scientific Corporation; MedtronicAfsluttetImplanterbar defibrillatorbrugerForenede Arabiske Emirater
-
University of AthensRekrutteringDilateret kardiomyopati | Pludselig hjertedød på grund af hjertearytmiGrækenland
-
Nantes University HospitalAfsluttetBrugada syndrom | S-ICD-system (implanterbar defibrillator)Spanien, Frankrig, Danmark, Tyskland, Italien